Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass : the pathophysiological role of GLP1 and its response to a somatostatin analogue. / Myint, K S; Greenfield, J R; Farooqi, I S; Henning, E; Holst, Jens Juul; Finer, N.

I: European Journal of Endocrinology, Bind 166, Nr. 5, 2012, s. 951-5.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Myint, KS, Greenfield, JR, Farooqi, IS, Henning, E, Holst, JJ & Finer, N 2012, 'Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue', European Journal of Endocrinology, bind 166, nr. 5, s. 951-5. https://doi.org/10.1530/EJE-11-1065

APA

Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012). Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. European Journal of Endocrinology, 166(5), 951-5. https://doi.org/10.1530/EJE-11-1065

Vancouver

Myint KS, Greenfield JR, Farooqi IS, Henning E, Holst JJ, Finer N. Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. European Journal of Endocrinology. 2012;166(5):951-5. https://doi.org/10.1530/EJE-11-1065

Author

Myint, K S ; Greenfield, J R ; Farooqi, I S ; Henning, E ; Holst, Jens Juul ; Finer, N. / Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass : the pathophysiological role of GLP1 and its response to a somatostatin analogue. I: European Journal of Endocrinology. 2012 ; Bind 166, Nr. 5. s. 951-5.

Bibtex

@article{e502fed0eb4f4e0685f7a96f2cb01e76,
title = "Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue",
abstract = "Spontaneous hyperinsulinaemic hypoglycaemia following gastric bypass surgery (GBS) is increasingly recognised. However, its pathophysiology remains unclear. Some patients require pancreatectomy. Medical therapy with calcium channel blockers, acarbose and diazoxide has been reported to be beneficial but has variable adherence and response.",
keywords = "Adult, Female, Gastric Bypass, Glucagon-Like Peptide 1, Humans, Nesidioblastosis, Octreotide, Somatostatin, Time Factors",
author = "Myint, {K S} and Greenfield, {J R} and Farooqi, {I S} and E Henning and Holst, {Jens Juul} and N Finer",
year = "2012",
doi = "10.1530/EJE-11-1065",
language = "English",
volume = "166",
pages = "951--5",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass

T2 - the pathophysiological role of GLP1 and its response to a somatostatin analogue

AU - Myint, K S

AU - Greenfield, J R

AU - Farooqi, I S

AU - Henning, E

AU - Holst, Jens Juul

AU - Finer, N

PY - 2012

Y1 - 2012

N2 - Spontaneous hyperinsulinaemic hypoglycaemia following gastric bypass surgery (GBS) is increasingly recognised. However, its pathophysiology remains unclear. Some patients require pancreatectomy. Medical therapy with calcium channel blockers, acarbose and diazoxide has been reported to be beneficial but has variable adherence and response.

AB - Spontaneous hyperinsulinaemic hypoglycaemia following gastric bypass surgery (GBS) is increasingly recognised. However, its pathophysiology remains unclear. Some patients require pancreatectomy. Medical therapy with calcium channel blockers, acarbose and diazoxide has been reported to be beneficial but has variable adherence and response.

KW - Adult

KW - Female

KW - Gastric Bypass

KW - Glucagon-Like Peptide 1

KW - Humans

KW - Nesidioblastosis

KW - Octreotide

KW - Somatostatin

KW - Time Factors

U2 - 10.1530/EJE-11-1065

DO - 10.1530/EJE-11-1065

M3 - Journal article

C2 - 22408121

VL - 166

SP - 951

EP - 955

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 5

ER -

ID: 40310985